Cancer News and Research

Latest Cancer News and Research

Synta prices underwritten public offering of 7,000,000 shares of common stock

Synta Pharmaceuticals Corp. announced today that it has priced an underwritten public offering of 7,000,000 shares of its common stock at a price to the public of $4.40 per share.

7 Jan 2012

Third Security, Transgenomic enter Convertible Promissory Note Purchase Agreement

Transgenomic, Inc. today announced that it has entered into a Convertible Promissory Note Purchase Agreement in the aggregate amount of $3.0 million with entities associated with Third Security, LLC, a leading life sciences investment firm.

7 Jan 2012

Annual screening tests do not decrease deaths from prostate cancer

There's new evidence that annual prostate cancer screening does not reduce deaths from the disease, even among men in their 50s and 60s and those with underlying health conditions, according to new research led by Washington University School of Medicine in St. Louis.

6 Jan 2012

Roundup: Miami police unions thwart health premiums increase; Washington's mandatory-abortion-coverage bill

Despite blunt warnings from Mayor Carlos Gimenez that their decision would force layoffs of hundreds of police and corrections officers, Miami-Dade commissioners Thursday narrowly refused to force two employee unions to contribute an additional 5 percent of their pay toward health insurance. ... The panel also refused to impose the controversial 5-percent giveback on its professionals and supervisor.

6 Jan 2012

First Edition: January 6, 2012

In today's news, reports from the campaign trail and details about how nine states have asked the federal government for more funding to make sure their high-risk pools don't run out of cash before 2014.

6 Jan 2012

GSK obtains exclusive license to ChemoCentryx's CCX354 CCR1 inhibitor for RA

ChemoCentryx, Inc., today announced that GlaxoSmithKline (GSK) has exercised its option to obtain an exclusive license for further development and worldwide commercialization of the investigational medicine CCX354, a potent and selective inhibitor of CCR1, a chemokine receptor that drives the recruitment of inflammatory cells into the joints of patients with rheumatoid arthritis (RA).

6 Jan 2012

TrovaGene enters definitive agreement to acquire MultiGEN

TrovaGene, Inc., a developer of trans-renal molecular diagnostics, today announced that it has entered into a definitive agreement to acquire MultiGEN Diagnostics, Inc.'s clinical laboratory assets in exchange for the issuance of 750,000 shares of common stock of TrovaGene, with an additional earn-out of up to $3.7 million in cash and common stock, subject to the achievement of specific sales and earnings targets.

6 Jan 2012

New imaging technology may pinpoint subtle aberrations in molecular biosignature of cancer

Despite advances in both the diagnosis and treatment of breast cancer, the disease remains a leading worldwide health concern.

6 Jan 2012

Endo, BDSI partner to develop and commercialize BEMA Buprenorphine for chronic pain

BioDelivery Sciences International, Inc. today announced the signing of a worldwide license and development agreement with Endo Pharmaceuticals for the exclusive rights to develop and commercialize BEMA Buprenorphine for the treatment of chronic pain.

6 Jan 2012

Scottsdale Healthcare is first in Arizona to perform TAVR procedure

Scottsdale Healthcare Osborn Medical Center is the first hospital in Arizona to perform a new nonsurgical heart valve replacement procedure, the Transcatheter Aortic Valve Replacement (TAVR). TAVR valves are inserted via a catheter through the femoral artery, without requiring open heart surgery.

6 Jan 2012

PDL settles exchange offer, announces final results

PDL BioPharma, Inc. today announced the settlement and final results of its offer to exchange up to $180,000,000 in aggregate principal amount of outstanding 2.875% Convertible Senior Notes due 2015 (Old Notes), for a like principal amount of new 2.875% Series 2012 Convertible Senior Notes due 2015 (New Notes), and a cash payment.

6 Jan 2012

Varenicline may reduce smoking rates before people try to quit

Smokers planning to kick the habit may have more success if they begin using a cessation medication several weeks before they actually try to quit.

6 Jan 2012

Study shows how Epstein-Barr virus triggers MS

A new study from researchers at Queen Mary, University of London shows how a particular virus tricks the immune system into triggering inflammation and nerve cell damage in the brain, which is known to cause MS.

6 Jan 2012

U.S. cancer death rates drop, new report says

In a new report from the American Cancer Society, researchers indicate that cancer death rates in the United States fell 1.8 percent in men and 1.6 percent in women each year between 2004 and 2008, but those gains weren't as pronounced in young adults.

6 Jan 2012

QIAGEN introduces QIAensemble Decapper to facilitate handling of liquid samples

QIAGEN N.V. announced today the launch of the QIAensemble Decapper automation system that will facilitate the handling of liquid-based cytology and various other types of liquid samples that are processed by clinical laboratories around the world.

From QIAGEN Manchester Limited 6 Jan 2012

Researchers use qHTS approach to examine clinical drugs on thyroid cancer cells

Drugs already approved for clinical use across a variety of therapeutic categories can be screened to identify effective agents for thyroid cancer according to a recent study accepted for publication in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

6 Jan 2012

Photoacoustic device can detect melanoma cancer at cellular level

Early detection of melanoma, the most aggressive skin cancer, is critical because melanoma will spread rapidly throughout the body. Now, University of Missouri researchers are one step closer to melanoma cancer detection at the cellular level, long before tumors have a chance to form. Commercial production of a device that measures melanoma using photoacoustics, or laser-induced ultrasound, will soon be available to scientists and academia for cancer studies.

6 Jan 2012

State roundup: Colo. reports 'record' number of Medicaid recipients; Hollywood nursing home stymied by Congress?

Nearly 615,000 Coloradans were on Medicaid in November, by far a record high, officials said Wednesday, attributing the vast bulk of the growth to economic hard times rather than recent eligibility expansions. ... the 614,146 Coloradans enrolled in Medicaid in November represented a 57.7 percent increase over January 2007. ... roughly 13 percent of all Coloradans are covered by state health-insurance programs.

6 Jan 2012

Proton therapy safe and effective for men with prostate cancer

Proton therapy, a type of external beam radiation therapy, is a safe and effective treatment for prostate cancer, according to two new studies published in the January issue of the International Journal of Radiation Oncology-Biology-Physics (Red Journal), the American Society for Radiation Oncology's (ASTRO) official scientific journal.

6 Jan 2012

Incidence of type 2 diabetes and hypertension increases with exposure to NOx

The incidence of type 2 diabetes and hypertension increases with cumulative levels of exposure to nitrogen oxides, according to a new study led by researchers from the Slone Epidemiology Center (SEC) at Boston University.

6 Jan 2012